HIVNAT 217:
Study title
Determinants of resilience in youth with HIV infection and youth affected by HIV
Study Code
HIVNAT 217
Network
HIVNAT
Study PI
Wasana Prasitsuebsai, MD
Study Co PI
Linda Aurpibul, M.D.
Study sites
Thailand
- Faculty of Medicine, Chulalongkorn University and the HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), the Thai Red Cross AIDS Research Centre, Bangkok, Thailand
- Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
- Srinagarind Hospital, Khon Kean University, Khon Kean, Thailand
- Queen Savang Vadhana Memorial Hospital, Chonburi, Thailand
- Nakornping Hospital, Chiang Mai, Thailand
- Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand
- Prapokklao Hospital, Chantaburi, Thailand
- Research Institute for Health Science and Faculty of Medicine Chiang Mai University
Cambodia
- National Pediatric Hospital, Phnom Penh, Cambodia
- Social Health Clinic, Phnom Penh, Cambodia
Funding agency
National Institute of Mental Health, National Institutes of Health, USA
Study design
prospective observational cohort study
Study objective
Objective 1: To identify the determinants of resilience in paHIV+ and HEU adolescents
Objective 2: To determine the neuroanatomical correlates for resilience
Objective 3: To examine determinants of resilience across culturally different settings, critical to assessment and treatment across contexts
Number of enrolled participants (overall/at RIHES)
Youth aged >10 years old will be included. They will be from the following groups
280 HIV-infected youth from the PREDICT cohort (140 immediate ART and 140 deferred ART)
150 perinatally HIV-exposed/HIV-negative youth
150 HIV-unexposed/HIV-negative youth
For Faculty of Medicine and Research Institutes for Health Sciences (RIHES), Chiang Mai University will enroll approximately 80 participants to the study.
Year: started
October 2014
Year: expected to finish
October 2018
Significance
The evaluation of resilience in adolescents as a sub study of PREDICT is relevant for the following reasons:
There are limited data about resilience determinants in HIV infected youth who have initiated ARVs at different CD4 percentages, do not have AIDS defining illnesses (CDC C), have not been exposed to substance use while in utero and are from resource-limited setting. This study will complement the main PREDICT study as well as other substudies, especially the neurodevelopment substudy, in obtaining knowledge to design appropriate and effective preventive interventions that will help promote health among paHIV+ and HEU youth worldwide to successfully transition into adulthood and the workforce.
There is limited information on the development of the prefrontal cortex in paHIV+ youth and its links to resilience.
No one has assessed the cognitive, neuroimaging, behavioral and mental health outcomes among adolescents with paHIV+ and HEU across different cultures.